OncLive: Dr. Mesa on remaining challenges faced in MPN treatment
October 16, 2020
In this video, Ruben Mesa, MD, executive director of the Mays Cancer, discusses the latest research on myeloproliferative neoplasms. Watch the interview.
News 4: Mays Cancer Center urges breast cancer screenings as many women put them off over COVID-19
October 13, 2020
Virginia Kaklamani, MD, professor of hematology/oncology, shares the breast cancer warning signs to look out for and how patients can be screened safely during COVID-19. Read and watch the story.
Dr. Mingjiang Xu receives UT System award to support cancer epigenetics research
October 9, 2020
Mingjiang Xu, MD, PhD, professor of molecular medicine, was awarded a $1 million UT System Faculty STARs award to enhance cancer epigenetics research and support the discovery of targeted therapeutics for blood cancers.
KENS 5: UT Health San Antonio doctor talks about the warning signs of throat cancer that Eddie Van Halen died from
October 7, 2020
Dr. Jay Ferrell, Otolaryngology, educated viewers about the warning signs of head and neck cancers, who is at risk, and the treatments available after news of the passing of guitar rock icon, Eddie Van Halen, who died of throat cancer at the age of 65. Watch the story.
The Cancer Letter: Ruben Mesa named executive director of the Mays Cancer Center
October 5, 2020
The second item in this briefs section is about Dr. Ruben Mesa, MD, FACP, being named executive director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson. Read the story.
Cardiovascular Business: Chemotherapy could be damaging children’s heart cells, leading to problems later in life
October 1, 2020
Results published in the journal PLOS ONE show that 20% of children treated with drugs called anthracyclines go on to suffer heart failure later in life. The research is conducted in the laboratory of Gregory Aune, MD, PhD, of the Department of Pediatrics and the Greehey Children’s Cancer Research Institute at UT Health San Antonio. Read […]